Quantcast

Adeona to Present at OneMedForum San Francisco 2011 Conference

January 6, 2011

ANN ARBOR, Mich., Jan. 6, 2011 /PRNewswire/ — Adeona Pharmaceuticals, Inc. (NYSE AMEX: AEN) , a developer of innovative medicines for serious central nervous system diseases, announced today that James S. Kuo, M.D., M.B.A., the Company’s Chief Executive Officer, will present at the OneMedForum San Francisco 2011 conference. Dr. Kuo will present at 1:45pm PST (4:45pm EST) on Tuesday, January 11, 2011 in the Renaissance Room at the Sir Francis Drake Hotel. A live webcast of Adeona’s presentation can be accessed by logging onto the web at http://www.ustream.tv/channel/onemedforum. After the presentation, a replay will be archived and accessible on Adeona’s website at www.adeonapharma.com.

About OneMedForum 2011

OneMedForum is a financial conference that includes industry-focused panel sessions, numerous networking opportunities and more than 125 presentations by some of the most promising emerging medical device, biotech and health information companies. OneMedForum San Francisco 2011 runs concurrently with the J.P. Morgan Healthcare Conference, providing efficient access to the companies shaping the future of the rapidly changing healthcare landscape. For more information, visit: www.onemedplace.com/forum/.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company’s strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing the following product candidates: a prescription medical food for Alzheimer’s disease, and drugs for multiple sclerosis, fibromyalgia, rheumatoid arthritis and age-related macular degeneration. For more information, please visit Adeona’s website at www.adeonapharma.com.

SOURCE Adeona Pharmaceuticals, Inc.


Source: newswire



comments powered by Disqus